| Structure | Chemical Name | CAS | MF | 
|  | Uridine, 5'-(2-methylpropanoate) (9CI) | 886538-48-3 | C13H18N2O7 | 
|  | Dapagliflozin Impurity 47 |  |  | 
|  | Crisaborole Impurity 17 |  |  | 
|  | Crisaborole Impurity 19 |  |  | 
| ![1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]-](../cas/20210305/gif/2514695-2d40-8.gif) | 1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]- | 2514695-40-8 | C20H18FNO4 | 
|  | 4-ethoxy-3-(4-pyridyl)-3-buten-2-one | 88349-61-5 | C11H13NO2 | 
| ![Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI)](../cas/20210305/gif/107021-2d20-5.gif) | Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) | 107021-20-5 | C9H14N5O4P | 
|  | Sitagliptin EP Impurity 7 |  |  | 
|  | Sitagliptin EP Impurity H |  |  | 
| ![7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]-](../cas/20210305/gif/2636673-48-6.gif) | 7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- | 2636673-48-6 | C18H26ClN3O4 | 
|  | Beprostatin impurity 4 |  |  | 
| ![cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole](../cas/20180808/gif/65621-78-5.gif) | cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole | 65621-78-5 | C17H16ClNO | 
|  | methyl tosylcarbamate | 14437-03-7 | C9H11NO4S | 
| ![(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium](../cas/20211123/gif/786598-71-8.gif) | (1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium | 786598-71-8 | C21H28NO3+ | 
|  | (+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl) | 147770-06-7 | C29H40N2O4 | 
|  | 4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride | 152402-97-6 | C7H8Cl3N | 
|  | 4-(3-CYANO-2-METHYLPROPIONYL)ACETAMILIDE | 42075-21-8 |  | 
| ![Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]](../cas/gif/119699-81-9.gif) | Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] | 119699-81-9 | C48H94N2O14Si2 | 
|  | Bimatoprost Impurity 11 |  |  | 
|  | Bimatoprost Impurity 9 |  |  | 
|  | Dolutegravir Impurity 18 |  |  | 
|  | PeraMpanel | 380918-53-6 | C23H15N3O | 
|  | Lenvatinib Impurity 33 |  |  | 
|  | isopropyl 2-(2-oxopyrrolidin-1-yl)acetate | 1249080-59-8 | C9H15NO3 | 
|  | Pitavastatin Impurity 71 |  |  | 
|  | Rosuvastatin EP Impurity M Sodium Salt |  |  | 
|  | Furosemide impurity 8 |  |  | 
|  | Febuxostat Impurity 108 |  |  | 
|  | Flucloxacillin EP Impurity J |  |  | 
| ![Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester](../cas/20200611/gif/1878175-77-9.gif) | Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester | 1878175-77-9 | C17H23N10O4P | 
| ![Acetic acid, 2-[[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]amino]-2-oxo-, ethyl ester](../cas/20200611/gif/480450-85-9.gif) | Acetic acid, 2-[[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]amino]-2-oxo-, ethyl ester | 480450-85-9 | C21H31N5O5S | 
| ![3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)-](../cas/20211123/gif/1193817-52-5.gif) | 3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)- | 1193817-52-5 | C33H35FN2O7 | 
|  | Hexanoic acid, 3-formyl-, ethyl ester | 54374-02-6 | C9H16O3 | 
|  | D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- | 154877-92-6 | C9H16O5 | 
|  | INDEX NAME NOT YET ASSIGNED | 2463617-49-2 | C51H56N16O4 | 
| ![Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-](../cas/20210111/gif/906673-43-6.gif) | Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- | 906673-43-6 | C14H11BO5 | 
|  | Benzenemethanamine, α,α'-sulfonylbis(methylene)bis[3-ethoxy-4-methoxy- | 2417213-71-7 | C22H32N2O6S | 
| ![1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-](../cas/20210111/gif/2138805-26-0.gif) | 1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- | 2138805-26-0 | C25H29ClN8O2 | 
| ![1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo-](../cas/20210111/gif/1651211-78-7.gif) | 1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- | 1651211-78-7 | C19H27I2N3O9 | 
|  | (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |  |  | 
|  | (R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |  |  | 
|  | Isavuconazole Impurity 37 |  |  | 
|  | "mixture of 2-amino-9-[[2-(hydroxymethoxy) ethoxy]methyl]-1,9-dihydro-6H-purin-6-one and 2-amino-9-[[2-(hydroxyethoxy)methoxy]methyl]-1,9- dihydro-6H-purin-6-one," |  |  | 
| ![N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide](../cas/20210305/gif/1375004-39-9.gif) | N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide | 1375004-39-9 | C29H39BN4O4 | 
|  | (S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |  |  | 
|  | Mannitol EP impurity B |  |  | 
|  | Mannitol EP impurity A |  |  | 
|  | Peramivir Amino Carboxylic Isomerism Impurity |  |  | 
|  | Peramivir Chlorinated Impurity |  |  | 
|  | Brivaracetam Impurity 999 |  |  | 
|  | Dasatinib impurity 48 |  |  | 
|  | Pemetrexed Impurity 120 |  |  | 
|  | Ticagrelor Impurity 101 |  |  | 
| ![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](../) | 4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |  |  | 
|  | Donepezil Impurity 3 | 1023500-88-0 | C24H27NO4 | 
|  | Fesoterodine Related Impurity 4 | 214601-12-4 | C22H29NO2 | 
|  | Prasugrel Impurity 14 Maleate | 1373350-60-7 | C24H25BrFNO7S | 
|  | Sofosbuvir Impurity 32 | 1157884-58-6 | C20H17FO6 | 
|  | Torsemide Related Compound 1 | 947327-54-0 | C13H13N3O2S | 
|  | Vortioxetine Impurity 3 | 508233-82-7 | C17H20N2S | 
|  | CYCLOPENTYL BENZOATE | 32651-38-0 | C12H14O2 | 
|  | D(-)-AMETHOPTERIN | 51865-79-3 | C20H22N8O5 | 
|  | (E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |  |  | 
|  | Aprepitant impurity 2 |  |  | 
|  | Aprepitant impurity 4 |  |  | 
|  | Vonoprazan Impurity B-2 |  |  | 
|  | 2-(Cyanomethylthio)acetic acid | 55817-29-3 | C4H5NO2S | 
|  | 2(1H)-Pyridinone, 1-(3-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)- | 2437650-75-2 | C15H19N3O2 | 
|  | 4(1H)-Pyridinone, 1-(6-methoxy-1H-benzimidazol-2-yl)-2,3,5-trimethyl- | 2512216-37-2 | C16H17N3O2 | 
|  | Budesonide Impurity 31 |  |  | 
|  | Budesonide Impurity 23 |  |  | 
|  | Hexanoic acid, 3-(chloromethyl)-, (3R)- | 2101641-90-9 | C7H13ClO2 | 
|  | Bisoprolol Impurity | 2226263-68-7 | C18H31NO4 | 
| ![2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)-](../cas/20210111/gif/1261219-83-3.gif) | 2(1H)-Quinolinone, 5-[(1R)-1,2-dihydroxyethyl]-8-(phenylmethoxy)- | 1261219-83-3 | C18H17NO4 | 
|  | Tofacitinib Impurity | 2504210-41-5 | C29H38N10O2 | 
|  | tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate |  |  | 
| ![2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)-](../cas/20210305/gif/2459302-85-1.gif) | 2-Pentenoic acid, 3-amino-2-cyano-5-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-5-oxo-, ethyl ester, (2E)- | 2459302-85-1 | C21H27N7O3 | 
|  | Avatrombopag Impurity 38 |  |  | 
|  | (1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) | 96946-55-3 | C53H72N2O12+2 | 
|  | Glycine, N-(2-aminobenzoyl)-, ethyl ester | 5973-34-2 | C11H14N2O3 | 
|  | 6-Chloro-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzoxanine-8-carboxylic acid | 123040-79-9 | C10H8ClNO4 | 
| ![3-Amino-3-azabicyclo[3.3.0]octane](../cas/gif/54528-00-6.gif) | 3-Amino-3-azabicyclo[3.3.0]octane | 54528-00-6 | C7H14N2 | 
|  | (S)-Methyl 2-aminobutanoate | 15399-22-1 | C5H11NO2 | 
| ![(6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one](../) | (6S,8S,9S,10R,11S,13S,14S,17R)-17-(2,2-dihydroxyacetyl)-11,17-dihydroxy-6,10,13-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |  |  | 
| ![(3aS-cis)-1,3-dibenzyltetrahydro-1H-thieno[3,4-d]imidazole-2,4-dione](../cas/gif/28092-52-6.gif) | (3aS-cis)-1,3-dibenzyltetrahydro-1H-thieno[3,4-d]imidazole-2,4-dione | 28092-52-6 | C19H18N2O2S | 
|  | methyl L-prolinate | 2577-48-2 | C6H11NO2 | 
|  | sodium (S,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate |  |  | 
|  | 3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one |  |  | 
|  | 2,4,6-tripropyl-1,3,5-trioxane | 2396-43-2 | C12H24O3 | 
| ![3-amino-5-[(methylthio)methyl]oxazolidin-2-one](../cas/gif/25517-72-0.gif) | 3-amino-5-[(methylthio)methyl]oxazolidin-2-one | 25517-72-0 | C5H10N2O2S | 
|  | 1-(3-((2,4-dimethylphenyl)thio)phenyl)piperazine hydrochloride | 2137793-92-9 |  | 
|  | Apixaban impurity 66S |  |  | 
|  | Aatrombopag Impurity 17 | 1268118-96-2 | C7H4BrClN2S2 | 
|  | (R)-(-)-2-AMINOBUTANAMIDE HYDROCHLORIDE, 97% | 103765-03-3 | C4H11ClN2O | 
|  | Flomoxef Impurity 20 Sodium Salt | 2095697-77-9 | C15H18F2N6O7S2 | 
|  | ((2R,3S,4R)-3,4,5-trihydroxytetrahydrofuran-2-yl)methyl isobutyrate | 2591381-21-2 | C9H16O6 | 
| amino]-5-(4-nitrophenyl)-, ethyl ester](../cas/20210305/gif/2591260-07-8.gif) | 3-Thiophenecarboxylic acid, 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-, ethyl ester | 2591260-07-8 | C25H23BrF2N2O6S | 
| ![Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel-](../cas/20210305/gif/190582-37-7.gif) | Cyclohexanecarboxylic acid, 2-[[[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]amino]carbonyl]-, (1R,2S)-rel- | 190582-37-7 | C23H32N4O3S | 
|  | Ivabradine Impurity II |  |  | 
| ![(1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](../cas/20211123/gif/792155-94-3.gif) | (1R,2R,4S,5S,7r)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate | 792155-94-3 | C18H19NO4S2 |